Related Experiment Video
Updated: Jul 3, 2025

07:48
Preparing a 68Ga-labeled Arginine Glycine Aspartate RGD-peptide for Angiogenesis
Published on: January 7, 2019
7.0K
RGD peptide in cancer targeting: Benefits, challenges, solutions, and possible integrin-RGD interactions
Hossein Javid1,2,3, Mahsa Akbari Oryani4, Nastaran Rezagholinejad5
1Department of Medical Laboratory Sciences, Varastegan Institute for Medical Sciences, Mashhad, Iran.
Cancer Medicine
|February 13, 2024
Summary
The RGD peptide facilitates cell adhesion by interacting with integrin receptors. This review explores RGD peptides
Area of Science:
- Biochemistry and Molecular Biology
- Biotechnology
- Biomedical Engineering
Background:
- The Arginine-Glycine-Aspartic (RGD) peptide sequence is a crucial motif found in cell adhesion and signaling proteins like fibronectin, vitronectin, and fibrinogen.
- RGD peptides mediate cell adhesion through interactions with integrin receptors on the cell surface, playing a vital role in biological processes.
Purpose of the Study:
- To review the diverse applications of RGD peptides in biotechnology and medicine.
- To highlight the potential of RGD peptides in targeted cancer therapy and drug delivery systems.
- To identify knowledge gaps and foster innovation in RGD peptide research for future drug development.
Main Methods:
- Literature review of existing research on RGD peptide applications.
- Analysis of RGD peptide interactions with integrin receptors.
- Exploration of RGD peptide incorporation into biomaterials, drug conjugates, and imaging agents.
Main Results:
- RGD peptides are extensively researched for their utility in biomaterials, drug conjugation, and imaging.
- RGD peptides enable targeted delivery to cancer cells and tumor vasculature by engaging integrins.
- RGD-functionalized drug carriers show promise for enhanced cancer therapy with reduced side effects.
Conclusions:
- RGD peptides offer a promising strategy for targeted drug delivery in cancer therapy.
- Further research into RGD peptides can significantly advance drug development and design.
- Understanding RGD peptide mechanisms can lead to improved therapeutic strategies and reduced adverse effects.
Related Concept Videos
Activation of Integrins
3.4K
Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
3.4K
Integrins
4.0K
Animal and protozoan cells do not have cell walls to help maintain shape and provide structural stability. Instead, these eukaryotic cells secrete a sticky mass of carbohydrates and proteins into the spaces between adjacent cells. This network of proteins and molecules is called an extracellular matrix or ECM.
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
4.0K
Small GTPases - Ras and Rho
4.0K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
4.0K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Intracellular Signaling Affects Focal Adhesions
2.7K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.7K
Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K

